Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia.
about
5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophreniaAutophagy in polyglutamine disease: Imposing order on disorder or contributing to the chaos?Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.Dopamine receptors - IUPHAR Review 13Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and 'Schizophrenia-Like Behaviors' in Mice.Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion.Striatal Transcriptome and Interactome Analysis of Shank3-overexpressing Mice Reveals the Connectivity between Shank3 and mTORC1 Signaling.Rhes suppression enhances disease phenotypes in Huntington's disease miceRhes: a GTP-binding protein integral to striatal physiology and pathology.Transcriptome Analysis of CD4+ T Cells in Coeliac Disease Reveals Imprint of BACH2 and IFNγ Regulation.p11 modulates L-DOPA therapeutic effects and dyskinesia via distinct cell types in experimental Parkinsonism.Effects of the Ras homolog Rhes on Akt/protein kinase B and glycogen synthase kinase 3 phosphorylation in striatum.RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network ("Rhesactome") in the striatum.Maladaptive Synaptic Plasticity in L-DOPA-Induced DyskinesiaRhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy.Dopaminergic modulation of striatal networks in health and Parkinson's disease.Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease.Rheb GTPase regulates β-secretase levels and amyloid β generationmTOR in Brain Physiology and Pathologies.PKA-mediated phosphorylation of Dexras1 suppresses iron trafficking by inhibiting S-nitrosylation.Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques.Signaling crosstalk between the mTOR complexes.mTOR Signaling in Parkinson's Disease.Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases.Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease.Striatum specific protein, Rhes regulates AKT pathway.Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia.The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging.Signal transduction in L-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression.
P2860
Q24299992-27462D22-25C4-489F-9E6C-351A11253054Q27011387-C53D96A3-E370-4C5F-9DC5-900B09477E3AQ27306293-1C348B2D-D053-426D-BBEC-8CDCA15723B5Q28256783-00E3E02E-20BB-499F-8C3C-0E28F0FBCFCFQ30364690-BE3EEB30-F91B-467B-B245-D0259AFF4D60Q30658223-14D18871-2EC7-4119-9649-F406C98A5001Q33843180-C78097FB-9C12-4549-896F-63E21E049710Q34071922-CFCC3EA2-3015-4D1B-9957-215BD4FB5A1BQ36095030-9CB08ADC-3144-47B3-A219-235D6796C1C2Q36132402-BCCCE13C-71F2-4AAB-BE05-BCD77423F03FQ36563103-2B928B11-5165-48C5-B494-12C6CEBB062CQ36680959-B0BE5FF9-C134-406C-88F5-E9016C0223E8Q37482165-F5F9DA31-EBC9-4E0D-BB56-76E57C97855FQ37516434-A3C7A583-95A7-465E-A20E-6A42ED6AFA23Q37563505-E875ACB2-CD19-4EB1-8236-4AF9C69B6A8DQ38233462-4612B283-0105-4C4E-9659-0A3212789BCEQ38447132-BE7D11FB-3649-448D-A348-35C3C7D9F4E4Q38451402-C6C5EB3D-6352-4928-BAAA-0BBEFB5A3531Q38565769-C4DC7161-6780-4B58-B7AE-7B4D495CC29BQ38629115-8745C785-CE1F-47EE-B67D-C7EDF5A3761FQ38662191-7FEA3E2D-BF61-48DB-B0DB-08B06C20922CQ38700659-2E20B2A7-8BEB-422C-AB79-D00E77272CF4Q38855225-43D1925D-85E2-4DAB-AA6A-5C62E92B558AQ39112358-CBCA8F3D-B5F0-4B86-96A6-24B71198A810Q39247355-E3779B3A-9CA2-412A-BC80-35A0BB7B4AAEQ41196900-877E480A-8810-44E5-8BF7-D2E25BFB5766Q42119034-0E505DAA-3DAC-4AFB-A1D6-DCD805459CF8Q42177230-60B33176-B40D-4438-9547-47A09CFB6E37Q48923348-4F8FE947-5153-4D9D-A104-87C355097F00Q49357267-B97D5CE8-9DAF-4F82-AFF5-D282CA3B49BE
P2860
Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Rhes, a striatal-enriched smal ...... and L-DOPA-induced dyskinesia.
@en
Rhes, a striatal-enriched smal ...... and L-DOPA-induced dyskinesia.
@nl
type
label
Rhes, a striatal-enriched smal ...... and L-DOPA-induced dyskinesia.
@en
Rhes, a striatal-enriched smal ...... and L-DOPA-induced dyskinesia.
@nl
prefLabel
Rhes, a striatal-enriched smal ...... and L-DOPA-induced dyskinesia.
@en
Rhes, a striatal-enriched smal ...... and L-DOPA-induced dyskinesia.
@nl
P2093
P2860
P50
P356
P1433
P1476
Rhes, a striatal-enriched smal ...... and L-DOPA-induced dyskinesia
@en
P2093
Neelam Shahani
Richa Tyagi
Robert G Mealer
Roxanne Barrow
Srinivasa Subramaniam
P2860
P2888
P304
P356
10.1038/NN.2994
P407
P577
2011-12-18T00:00:00Z